Jan Zijlstra
Jan Zijlstra
Unknown affiliation
Verified email at planet.nl
Cited by
Cited by
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
D Annane, V Sébille, C Charpentier, PE Bollaert, B François, JM Korach, ...
Jama 288 (7), 862-871, 2002
A randomized trial of glutamine and antioxidants in critically ill patients
D Heyland, J Muscedere, PE Wischmeyer, D Cook, G Jones, M Albert, ...
New England Journal of Medicine 368 (16), 1489-1497, 2013
Decontamination of the digestive tract and oropharynx in ICU patients
A De Smet, J Kluytmans, BS Cooper, EM Mascini, RFJ Benus, ...
New England Journal of Medicine 360 (1), 20-31, 2009
Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line
JG Zijlstra, EGE de Vries, NH Mulder
Cancer Research 47 (7), 1780-1784, 1987
Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials
JL Vincent, RJ Navickis, MM Wilkes
Critical care medicine 32 (10), 2029-2038, 2004
Leukocyte activation in sepsis; correlations with disease state and mortality
ACM Kobold, JE Tulleken, JG Zijlstra, W Sluiter, J Hermans, ...
Intensive care medicine 26 (7), 883-892, 2000
Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature
S Meijering, AM Corstjens, JE Tulleken, JHJM Meertens, JG Zijlstra, ...
Critical Care 10 (1), 1-7, 2006
Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients
AM Corstjens, JJM Ligtenberg, ICC van der Horst, R Spanjersberg, ...
Critical Care 10 (5), 1-7, 2006
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line
S de Jong, JG Zijlstra, EGE de Vries, NH Mulder
Cancer research 50 (2), 304-309, 1990
Quality of interhospital transport of critically ill patients: a prospective audit
JJM Ligtenberg, LG Arnold, Y Stienstra, TS van der Werf, JHJM Meertens, ...
Critical Care 9 (4), 1-6, 2005
Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD
ML Duiverman, JB Wempe, G Bladder, DF Jansen, HAM Kerstjens, ...
Thorax 63 (12), 1052-1057, 2008
Increased circulating endothelial progenitor cells in septic patients: correlation with survival
N Rafat, C Hanusch, PT Brinkkoetter, J Schulte, J Brade, JG Zijlstra, ...
Critical care medicine 35 (7), 1677-1684, 2007
Blunted rise in platelet count in critically ill patients is associated with worse outcome
MWN Nijsten, HJ ten Duis, JG Zijlstra, RJ Porte, JH Zwaveling, JC Paling
Critical care medicine 28 (12), 3843-3846, 2000
Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial
ML Duiverman, JB Wempe, G Bladder, JM Vonk, JG Zijlstra, ...
Respiratory research 12 (1), 1-10, 2011
Quality of interhospital transport of the critically ill: impact of a Mobile Intensive Care Unit with a specialized retrieval team
JS Wiegersma, JM Droogh, JG Zijlstra, J Fokkema, JJM Ligtenberg
Critical care 15 (1), 1-8, 2011
Bench-to-bedside review: Angiopoietin signalling in critical illness–a future target?
M van Meurs, P Kümpers, JJM Ligtenberg, JHJM Meertens, G Molema, ...
Critical care 13 (2), 1-13, 2009
Organophosphorus pesticide poisoning: cases and developments
H Aardema, JH Meertens, JJ Ligtenberg, OM Peters-Polman, JE Tulleken, ...
Neth J Med 66 (4), 149-53, 2008
P-glycoprotein expression and DNA topoisomerase I and II activity in benign tumors of the ovary and in malignant tumors of the ovary, before and after platinum/cyclophosphamide …
AGJ van der Zee, H Hollema, S de Jong, H Boonstra, A Gouw, ...
Cancer research 51 (21), 5915-5920, 1991
Transferring the critically ill patient: are we there yet?
JM Droogh, M Smit, AR Absalom, JJM Ligtenberg, JG Zijlstra
Critical Care 19 (1), 1-7, 2015
Suppression of the clinical and cytokine response to endotoxin by RWJ‐67657, a p38 mitogen‐activated protein‐kinase inhibitor, in healthy human volunteers
JW Fijen, JG Zijlstra, P De Boer, R Spanjersberg, JW Cohen Tervaert, ...
Clinical & Experimental Immunology 124 (1), 16-20, 2001
The system can't perform the operation now. Try again later.
Articles 1–20